Advisory Committees

Obstetrics and Gynecology Devices Panel

June 24, 2015: FDA plans to hold a meeting of the Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee to discuss the risks and benefits of Bayer HealthCare’s Essure System for permanent female sterilization (P020014). The meeting will be held on September 24, 2015.

The Obstetrics and Gynecology Devices Panel reviews and evaluates data concerning the safety and effectiveness of marketed and investigational in vitro devices for use in clinical laboratory medicine including clinical and molecular genetics and makes appropriate recommendations to the Commissioner of Food and Drugs.

Designated Federal Official (DFO)
Shanika Craig

Past Meetings

Page Last Updated: 06/25/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.